Clinical Trial

Feasibility of Remote Exercise Training for Hispanics/Latinos With MS

Study acronym: FERLAMS
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
The study was terminated early due to NIH funding withdrawal before reaching the planned sample size of 50 participants. Thirty-three participants enrolled, 30 were randomized, and 26 completed follow-up assessments.
Summary
The goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS). The main questions it aims to answer are: * Can a 4-month remotely-delivered exercise training program improve physical function, symptom management, and quality of life in Hispanics/Latinos with MS? * How do social determinants of health, such as income, education, access to healthcare, and social support, influence the feasibility and effectiveness of the exercise intervention? Participants in this study will engage in a 4-month remotely-delivered exercise training intervention that includes flexibility, or aerobic and resistance exercise training sessions. They will work with experienced coaches who will guide and support them throughout the program. The researchers will compare the participants who receive the exercise intervention with a control group to see if the exercise program leads to significant improvements in physical function, fatigue, mood, and overall well-being for Hispanics/Latinos with MS. The study aims to empower this underserved population and provide insights for future healthcare and research initiatives.
Protocol Amendment History 2 changes
critical Trial status changed: Completed → Terminated 2026-08-08
critical Trial terminated: The study was terminated early due to NIH funding withdrawal before reaching the planned sample size of 50 participants... 2026-08-08
Trial Details
NCT Number NCT05998616
Lead Sponsor University of Illinois at Chicago
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions Multiple Sclerosis
Enrollment 33 participants
Start Date 2024-04-27
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07